Antiarrhythmics or Ablation for Ventricular Tachycardia 2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony L Tang, MD FRCPC
London Health Sciences Centre
Study Director - George A Wells, BSc MSc PhD
Ottawa Heart Institute Research Corporation
Study Director - Jeff Healey, MD FRCPC
Population Health Research Institute, McMaster University
Study Director - John L Sapp, MD FRCPC
Nova Scotia Health Authority
Principal Investigator - Ratika Parkash, MD MSc FRCPC
Nova Scotia Health Authoriry
Study Director - William G Stevenson, MD
Brigham and Women's Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Foothills Hospital
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Interior Health Authority
Kelowna, British Columbia, Canada
- St. Paul'S Hospital
Vancouver, British Columbia, Canada
- Royal Jubilee Hospital
Victoria, British Columbia, Canada
- Nova Scotia Health Authority
Halifax, Nova Scotia, Canada
- Hamilton Health Sciences Center
Hamilton, Ontario, Canada
- Queen'S University Health Sciences Centre
Kingston, Ontario, Canada
- St. Mary'S Hospital
Kitchener, Ontario, Canada
- London Health Sciences Centre
London, Ontario, Canada
- University of Ottawa Heart Institute
Ottawa, Ontario, Canada
- St. Michael'S Hospital
Toronto, Ontario, Canada
- Centre Hospitalier de L'Universitaire de Montreal
Montreal, Quebec, Canada
- Mcgill University Health Center
Montreal, Quebec, Canada
- Montreal Heart Institute
Montreal, Quebec, Canada
- Sacre-Coeur Hospital
Montreal, Quebec, Canada
- Institut Universitaire de Cardiologie Et Pneumologie de Quebec - Laval University Hosptial
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
- Hopitaux de Bordeaux
Bordeaux, Acquitaine, France
- Chu - University Hospital Nancy
Nancy, Meurthe-et-Moselle, France
- Hartford General Hospital
Hartford, Connecticut, United States
- Vanderbilt University Hospital
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2016
- Primary completion
- 6 Jun 2024
- Completion
- 30 Jun 2024
- Last update posted
- 1 Aug 2024
- Registered enrollment
- 416
- Registry id
- NCT02830360
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.